U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C21H24F3N3O4
Molecular Weight 439.4282
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of LASCUFLOXACIN

SMILES

COC1=C2N(CCF)C=C(C(O)=O)C(=O)C2=CC(F)=C1N3C[C@@H](F)[C@@H](CNC4CC4)C3

InChI

InChIKey=ZFIOCUITTUUVPV-MEDUHNTESA-N
InChI=1S/C21H24F3N3O4/c1-31-20-17-13(19(28)14(21(29)30)9-26(17)5-4-22)6-15(23)18(20)27-8-11(16(24)10-27)7-25-12-2-3-12/h6,9,11-12,16,25H,2-5,7-8,10H2,1H3,(H,29,30)/t11-,16+/m0/s1

HIDE SMILES / InChI

Molecular Formula C21H24F3N3O4
Molecular Weight 439.4282
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

LASCUFLOXACIN, a fluoroquinolone derivative, is an antibacterial agent with a broad spectrum of activity against various clinical isolates. It is under development for the treatment of respiratory tract infections and community-acquired pneumonia.

Approval Year

PubMed

PubMed

TitleDatePubMed
In Vitro Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977).
2017 Jun
Intrapulmonary Pharmacokinetics of Lascufloxacin in Healthy Adult Volunteers.
2018 Apr
In vitro activity of lascufloxacin, a novel fluoroquinolone antibacterial agent, against various clinical isolates of anaerobes and Streptococcus anginosus group.
2018 Dec
In Vitro Mechanistic Study of the Distribution of Lascufloxacin into Epithelial Lining Fluid.
2019 Apr
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:41:47 UTC 2023
Edited
by admin
on Fri Dec 15 16:41:47 UTC 2023
Record UNII
55MOB566V7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
LASCUFLOXACIN
INN   WHO-DD  
INN  
Official Name English
7-((3S,4S)-3-((CYCLOPROPYLAMINO)METHYL)-4-FLUOROPYRROLIDIN-1-YL)-6-FLUORO-1-(2-FLUOROETHYL)-8-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID
Systematic Name English
3-QUINOLINECARBOXYLIC ACID, 7-((3S,4S)-3-((CYCLOPROPYLAMINO)METHYL)-4-FLUORO-1-PYRROLIDINYL)-6-FLUORO-1-(2-FLUOROETHYL)-1,4-DIHYDRO-8-METHOXY-4-OXO-
Systematic Name English
Lascufloxacin [WHO-DD]
Common Name English
lascufloxacin [INN]
Common Name English
Code System Code Type Description
DRUG CENTRAL
5370
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
WIKIPEDIA
Lascufloxacin
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
SMS_ID
300000019094
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
PUBCHEM
71528768
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
INN
10017
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
EPA CompTox
DTXSID001336967
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
CAS
848416-07-9
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
NCI_THESAURUS
C166817
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
FDA UNII
55MOB566V7
Created by admin on Fri Dec 15 16:41:47 UTC 2023 , Edited by admin on Fri Dec 15 16:41:47 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
TARGET ORGANISM->INHIBITOR
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY